This inventor holds 1 USPTO granted patent. Top assignees: Toyo Kohan Co., Ltd., Yamaguchi University. Active years: 2023.
Company Filing History:
1 out of 260 
1 out of 88 Years Active: 2023
Title: Hideyasu Matsuyama: Innovator in Pharmacokinetics
Introduction
Hideyasu Matsuyama is a notable inventor based in Ube, Japan. He has made significant contributions to the field of pharmacokinetics, particularly concerning the drug axitinib. His work aims to enhance the understanding and prediction of therapeutic effects based on pharmacokinetic parameters.
Latest Patents
Matsuyama holds a patent titled "Method for determining pharmacokinetics of axitinib and method for predicting therapeutic effect of axitinib based on pharmacokinetics of axitinib." This invention is designed to conveniently determine the pharmacokinetics of axitinib and predict its therapeutic effects. The method involves calculating a predicted pharmacokinetic parameter of axitinib using specific gene polymorphisms and background factors related to the test subject. He has 1 patent to his name.
Career Highlights
Throughout his career, Matsuyama has worked with esteemed institutions, including Yamaguchi University and Toyo Kohan Co., Ltd. His research has contributed to advancements in the understanding of drug interactions and patient-specific treatment plans.
Collaborations
Matsuyama has collaborated with notable colleagues such as Mitsuyoshi Oba and Yoshihiko Hamamoto. Their joint efforts have furthered research in pharmacokinetics and therapeutic predictions.
Conclusion
Hideyasu Matsuyama's innovative work in pharmacokinetics represents a significant advancement in the field of medicine. His contributions are vital for improving patient outcomes through personalized treatment strategies.